Good morning everyone, Part 4 of the LIPAGLYN MASLD PRO 2025 is at 8:30 p.m. tonight (25-February-25). These are the topics we will be discussing tonight: 1. Outline for management of MASLD & Role for Lifestyle measures in management of MASLD 2. Role of Currently approved medications in management of MASLD - including the role of Saroglitazar (LIPAGLYN) & Resmetirom 3. Reusing existing drugs for management of MASLD (GLP1 RA, Pioglitazone, SGLT2i etc) 4. Future drugs and therapies in management of MASLD & drugs that you SHOULD NOT be using in MASLD 5. How to get the certificate at the end of the course This will be the concluding lecture in this series Please join for the lecture at 8:30 p.m. If you have signed up for the first lecture, you will receive the link automatically from Zoom. Please check your spam folder if you have not received the email. If not, you can view the lecture on our Endocrinology India YouTube channel: https://www.youtube.com/@EndocrinologyIndia If not done already, please also sign up on our Technocrinology.com platform to get access to all the previous lectures, notes on the current lectures, and tools and applications: https://technocrinology.thinkific.com/courses/masld Thanks and regards, Dr. Om J Lakhani